Sutro Biopharma reports Q1 2026 financial results
Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read
Key Changes
-
medium
Sutro Biopharma announced Q1 2026 financial results for the quarter ended March 31, 2026 via press release. The 8-K references the attached press release but does not include specific financial metrics in the filing body.
Item 2.02 verify on EDGAR →
See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.
Partner
Trade STRO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 9, 2026 4:41 PM